AbbVie | ABBV - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2026 3.84 1.86 Oct/30
FY2026Q2 Jun/2026 3.65 3.76 2.97 Jul/31
FY2026Q1 Mar/2026 2.65 3.01 2.46 Apr/29
FY2025Q4 Dec/2025 2.71 3.35 2.16 Feb/04
FY2025Q3 Sep/2025 1.86 3.26 3.00 Oct/31




Eps Alterar Data
AbbVie USD 3.65 1 2026-06
Abbott USD 0.53 0.78 2026-09
ALKERMES USD 0 0.4 2026-06
Amgen USD 6.29 1.14 2026-06
AstraZeneca USD 2.63 0.05 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Coherus Biosciences USD -0.43 0.06 2025-12
Eisai JPY 64.71 76.24 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
J&J USD 2.7 0.2 2026-09
Medtronic USD 1.45 0.1 2026-06
Merck USD -0.13 1.15 2026-06
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 2.41 0.42 2026-06
Pacira USD 0.73 0.13 2026-06
Perrigo USD 0.5 0.07 2026-06
Pfizer USD 0.77 0.02 2026-06
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Roche Holding CHF 10.98 2.61 2026-06
Sanofi EUR 2.09 0.21 2026-06
UCB EUR 5.65 3.21 2025-12
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
United Therapeutics USD 7.27 1.45 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06
Zoetis USD 1.87 0.34 2026-06